October 28, 2016

In a move that would expand its oncology pipeline, Astellas Pharma announced Friday its agreement to acquire Ganymed Pharmaceuticals for €422 million, or about $461 million. 

October 28, 2016
Bloomberg BNA is reporting that the Food and Drug Administration’s director of the Center for Drug Evaluation and Research’s Office of New Drugs told an audience at the DIA Biosimilars Conference that manufacturers looking to submit an application for biosimilar approval should know what the FDA is looking for when evaluating a biosmilar for approval. Jenkins said that rather than the focus on safety and efficacy it places on standalone biologics, with biosimilars, it focvuses on how closely it resembles the reference product, something he called “a work in progress” for some drug makers. (Bloomberg BNA)
 
October 27, 2016
Crain’s Detroit Business is reporting that Flint, Mich.-based Diplomat Pharmacy’s stock is feeling the effect of Tuesday announcement that president Gary Kadlec and the company’s CFO Sean Whelan would be departing the company by year’s end. After the announcement, the company’s shares fell 12.36% Wednesday, the report says, hitting a new 52-week low. The company is set to release its Q3 earnings report next week. (Crain’s Detroit Business)
 
October 26, 2016

Diplomat Pharmacy has announced big changes to its leadership team, including a new president and the departure of its CFO.

October 26, 2016

Among the reasons for the  name change was the organization’s expansion beyond its founders’ focus on biotechnology. 

October 26, 2016
LAS VEGAS — In a move aimed at addressing the two challenges of discovering new options for treatment and improving chronic disease management, Teva and IBM on Wednesday announced an expansion of their e-health alliance, with both projects running on the IBM Watson Health Cloud.   
October 25, 2016

Diplomat Pharmacy on Tuesday announced that, in honor of American Pharmacists Month, it would be hosting a Diplomat Dialogue series that would take a closer look at the role of pharmacists.

October 21, 2016

Endo SVP global finance operations Blaise Coleman will serve as interim CFO, and Endo said it would begin a search for a permanent replacement for Upadhyay. 

October 21, 2016

Thrifty White offers its specialty patients full pharmacy support services and has expanded its capabilities to serve specialty patients in all 50 states, in addition to the specialty medication pickup it offers at 90 of its retail locations. 

October 19, 2016

Camber Pharmaceuticals announced Wednesday that its parent company, Hetero Drugs, has been recognized by Gilead Sciences for its work providing access to hepatitis C drugs for patients worldwide.

October 19, 2016

The report, compiled on behalf of the Generic Pharmaceutical Association, found that in 2015, generic drugs brought patients and the U.S. healthcare system 227 billion in savings, bringing the savings since 2005 from generics to $1.46 trillion. 

October 19, 2016

Drug Store News recently spoke with Walgreens Specialty Pharmacy group VP Gerry Gleeson about the company’s approach to specialty and the importance of a focus on patient care and pharmacist education in that space.

October 18, 2016
Inflectra will be the second biosimilar available in the United States, and the first biosimilar monoclonal antibody. 
October 17, 2016

Specialty medicines made up 36% of all drug spend for the year ended May 2016, according to IMS Health data.

October 11, 2016

Diplomat Pharmacy on Tuesday announced that it is celebrating specialty pharmacists during American Pharmacists Month with a campaign aimed at exploring the role of pharmacists working in specialty. 

October 6, 2016
Under the agreement, Lupin would develop multiple pediatric products using Monosol Rx’s PharmFilm drug delivery technology. 
October 6, 2016

Teva and Celltrion on Thursday announced a new exclusive partnership centered on commercializing two of Celltrion’s biosimilar candidates in the United States and Canada. 

September 28, 2016

Thrifty White recently expanded its capabilities to service specialty patients in all 50 states, and it offers specialty medication pickup at 90 retail locations.

September 27, 2016

BioPlus Specialty Pharmacy announced Tuesday that it had received accreditation from the Accreditation Commission for Health Care (ACHC) with a distinction in oncology. 

September 27, 2016

Walgreens will offer its specialty pharmacists on-demand and live education courses on many of the most prevalent specialty pharmacy-managed disease states, including oncology, fertility, hepatitis C, cystic fibrosis, multiple sclerosis and chronic inflammatory/autoimmune diseases. 

September 26, 2016

Amjevita is the fourth approved biosimilar in the United States, and Amgen’s first approved biosimilar. 

September 26, 2016

Janssen Biotech announced Monday that the Food and Drug Administration had approved its Stelara (ustekinumab) to treat moderately to severely active Crohn’s disease.  

September 26, 2016

Pfizer announced Monday that its board of directors and executive leadership team had decided not to split the company into two separate companies, Pfizer Innovative Health and Pfizer Essential Health. The two will remain separately managed units within Pfizer. 

September 21, 2016

Allergan will be acquiring Akarna Therapeutics and its portfolio of developing treatments for an upfront payment of $50 million plus potential clinical, regulatory and commercial milestone payments around its lead compound AKN-083.